Some good news today - we've just launched our clinical trial MUK eleven which will open to recruitment imminently.
This trial is the first of its kind and focuses on trying to strengthen the effectiveness of treatments for relapsing myeloma patients. Find out more: bit.ly/2mvFFC9
